Page last updated: 2024-08-17

cordycepin and Uterine Cervical Neoplasms

cordycepin has been researched along with Uterine Cervical Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halim, MA; Khan, MA; Khorram, MS; Kiefer, R; Saif, K; Shawon, J; Tania, M1
Hong, S; Kim, WD; Muthusami, S; Park, WY; Seong, da B; Yu, JR1
Scorilas, A; Thomadaki, H; Tsiapalis, CM1

Other Studies

3 other study(ies) available for cordycepin and Uterine Cervical Neoplasms

ArticleYear
Cordycepin Downregulates Cdk-2 to Interfere with Cell Cycle and Increases Apoptosis by Generating ROS in Cervical Cancer Cells: in vitro and in silico Study.
    Current cancer drug targets, 2019, Volume: 19, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Computer Simulation; Cyclin-Dependent Kinase 2; Deoxyadenosines; Female; HeLa Cells; Humans; In Vitro Techniques; Reactive Oxygen Species; Tumor Cells, Cultured; Uterine Cervical Neoplasms

2019
Cordycepin increases radiosensitivity in cervical cancer cells by overriding or prolonging radiation-induced G2/M arrest.
    European journal of pharmacology, 2016, Jan-15, Volume: 771

    Topics: Apoptosis; Cell Division; Cell Line, Tumor; Cell Survival; Deoxyadenosines; Female; G2 Phase; Gene Expression; Genes, cdc; Genes, p53; HeLa Cells; Humans; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms

2016
Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction.
    Biological chemistry, 2005, Volume: 386, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 6; Caspases; Cell Cycle; Cell Line, Tumor; Deoxyadenosines; DNA Fragmentation; Etoposide; Female; Humans; Isoenzymes; Neoplasms, Glandular and Epithelial; Polynucleotide Adenylyltransferase; Time Factors; Uterine Cervical Neoplasms

2005